European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients

NCT00217763 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

930

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: 3APS

Sponsor

Bellus Health Inc. - a GSK company